Literature DB >> 20173688

A clinical pathway including psychotherapy approaches for managing emotional difficulties after acquired brain injury.

Rudi Coetzer1.   

Abstract

Emotional difficulties, such as anxiety and depression, are common after acquired brain injury in adults and can influence long-term outcome. Diagnosis in a brain injury context can be difficult. Ideally, rehabilitation approaches should consider the specific treatment of anxiety and depression as well and may include pharmacotherapy, individual psychotherapy, and family interventions. Psychotherapy, especially in regards to longer-term adjustment to brain injury, may have an important adjunctive role in treatment approaches, but adaptations of techniques may be needed. A clinical pathway is described which can help to raise clinicians awareness, as well as increase detection rates and consideration of the specific role of individual psychotherapy in this clinical population. However, an important caveat is that clinical pathways should not serve as a substitute, but rather a facilitator, for the process of reasoning about individual patients in everyday clinical practice.

Entities:  

Mesh:

Year:  2009        PMID: 20173688     DOI: 10.1017/s1092852900023877

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  3 in total

Review 1.  [Treatment pathways in the care of patients with schizophrenia and depression].

Authors:  H J Salize; E Voß; A Werner; P Falkai; I Hauth
Journal:  Nervenarzt       Date:  2015-11       Impact factor: 1.214

Review 2.  [Development of an internet-based clinical pathway exemplified by the fibromyalgia syndrome].

Authors:  M Noll-Hussong
Journal:  Schmerz       Date:  2012-04       Impact factor: 1.107

Review 3.  Using the Generic Model of Psychotherapy to Develop a Culturally-Sensitive Approach to Psychotherapy With Sexual and Gender Minority Patients.

Authors:  Alemka Tomicic; Claudio Martínez; Juliana Rodríguez
Journal:  Front Psychol       Date:  2020-12-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.